Ferronova
Australia - Mawson LakesBiotechnology
Focus: Ferronova is an Australian biotech company focused on cancer imaging, specifically developing sentinel lymph node mapping solutions for oncology applications. The company is at Series A stage, indicating early-stage development with significant growth potential but limited scale.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
SERIES A
Total Funding
$3.5M
Open Jobs
0
About Ferronova
AI assessmentNot HiringNo open roles listed right now. Follow Ferronova to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
FerroTrace® and FerroMag Sentinel Lymph Node Mapping
Gastric CancerClinical Trials (1)
NCT05899985Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation
N/AHelp build intelligence for Ferronova
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.